Phase 1/2 study of LR 06B
Latest Information Update: 13 Oct 2022
At a glance
- Drugs LR-06 (Primary)
- Indications Breast cancer; Ovarian cancer; Pancreatic cancer
- Focus Adverse reactions
Most Recent Events
- 13 Oct 2022 New trial record
Latest Information Update: 13 Oct 2022